Monday, March 17, 2025
HomeIndustriesHealthcare

Healthcare

CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid...

Halo Labs Launches New Instruments for Protein, Cell, and Gene Therapy Developers

Halo Labs, a life science instrumentation company developing tools for biologics researchers, announced that it has launched its latest products - Aura+™and Aura PTx™. Also...

WuXi Biologics Completes Inspection by South Korea’s Ministry of Food and Drug Safety

WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by...

Ionis’ partner to evaluate tominersen for Huntington’s disease in new Phase 2 trial

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that its partner, Roche, is designing a new Phase 2 trial to evaluate tominersen in Huntington's disease (HD)....

Sciwind Biosciences Begins Phase 2b Clinical Trial Of Obesity Drug Candidate

Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced the initiation of patient...
0FansLike
0FollowersFollow
spot_img

Hot Topics